CALGB 9840: Phase III study of weekly (W) paclitaxel (P) via 1-hour(h) infusion versus standard (S) 3h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC-Reference-Cited by-同舟云学术

CALGB 9840: Phase III study of weekly (W) paclitaxel (P) via 1-hour(h) infusion versus standard (S) 3h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC

Published:2004-07-15 Issue:14_suppl Volume:22 Page:512-512
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Seidman A. D.¹,Berry D.¹,Cirrincione C.¹,Harris L.¹,Dressler L.¹,Muss H.¹,Norton L.¹,Winer E.¹,Hudis C.¹

Affiliation:

1. Memorial Sloan-Kettering Cancer Center, New York, NY; University of Texas - M.D. Anderson Cancer Center, Houston, TX; Duke University Medical Center, Durham, NC; Dana-Farber Cancer Center, Boston, MA; Univ. of North Carolina at Chapel Hill, Chapel Hill, NC; University of Vermont, Burlington, VT

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.512

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer;Breast Cancer Research and Treatment;2010-06-26

2. Alternative dosing schedules and administration updates for Ixabepilone;Journal of Oncology Pharmacy Practice;2010-03-09

3. Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000–2007;European Journal of Cancer;2008-10

4. Treatment of metastatic breast cancer: looking towards the future;Breast Cancer Research and Treatment;2008-05-09

5. Clinical Efficacy of Taxane–Trastuzumab Combination Regimens for HER-2–Positive Metastatic Breast Cancer;The Oncologist;2008-05-01